Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR‐379‐5p

BACKGROUND: Cisplatin (DDP) treatment is one of the most predominant chemotherapeutic strategies for lung cancer patients. Circular RNAs (circRNAs) have been revealed to participate in the chemoresistance in lung cancer. Hence, the role and mechanism of circ_0010235 in cisplatin resistance in lung c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lifei, Wang, Dongchang, Xu, Zhen, Qiu, Yali, Chen, Gang, Tan, Furong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344743/
https://www.ncbi.nlm.nih.gov/pubmed/37277864
http://dx.doi.org/10.1111/1759-7714.14941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344743/
https://www.ncbi.nlm.nih.gov/pubmed/37277864
http://dx.doi.org/10.1111/1759-7714.14941

Ejemplares similares